To preliminarily validate the relationship between the above-identified RBPs and associated clinicopathologic features, we explored the role of PCBP2 in the proliferative and migratory ability of bladder cancer cells given the potential regulation of PCBP2 to “neoplasm histologic grade”-related ASEs in BLCA. Here, PCBP2 is linked to urinary bladder carcinoma.